ArticleInternational journal of endocrinology2014

Dipeptidyl peptidase-4 inhibitors as a third-line oral antihyperglycaemic agent in patients with type 2 diabetes mellitus: the impact of ethnicity.

X Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.